A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors
- Author(s)
- McLean, LS; Lim, AM; Angel, C; Young, RJ; Pizzolla, A; Archer, S; Solomon, BJ; Thai, AA; Lewin, J; Rischin, D;
- Details
- Publication Year 2024-04-10,Volume 16,Issue #8,Page 1452
- Journal Title
- Cancers
- Publication Type
- Research article
- Abstract
- Non-melanomatous cutaneous spindle cell neoplasms are a rare group of malignancies that present a diagnostic challenge, and for which there is a lack of consensus on how to best manage patients with advanced disease and only limited reports of immune-checkpoint inhibitor (ICI) responses. In this study, we performed a single-center retrospective review of treatment outcomes for all advanced non-melanomatous cutaneous spindle cell neoplasms treated with ICIs. Blinded histopathology reviews occurred to confirm each diagnosis. Comprehensive tumour profiling included whole exome sequencing for tumour mutational burden (TMB) and ultraviolet(UV) signatures, and immunohistochemistry for immune-cell infiltration (CD4/CD3/CD8/CD103/CD20) and immune-checkpoint expression (PD-L1/LAG3/TIGIT). Seven patients were identified. The objective response rate was 86% (6/7) with five complete responses (CR). Responses were durable with two patients in CR > 30 months after ICI commencement. All patients had high TMB and UV signatures. One patient had PD-L1 100% (combined positive score) with abundant immune-cell infiltration and LAG3 expression. In advanced non-melanomatous cutaneous spindle cell neoplasms, excellent responses to ICIs with durable disease control were observed. ICIs are worthy of further exploration in these patients. UV signatures and high TMB could be used to help select patients for treatment.
- Publisher
- MDPI
- Keywords
- biomarkers; cutaneous spindle cell neoplasm; immune-checkpoint inhibitors; immunotherapy
- Department(s)
- Medical Oncology; Pathology; Laboratory Research
- Publisher's Version
- https://doi.org/10.3390/cancers16081452
- Open Access at Publisher's Site
https://doi.org/10.3390/cancers16081452- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-07-16 07:55:48
Last Modified: 2024-07-16 07:59:12